Viatris Settles EpiPen Antitrust Litigation for $264 Million

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100.The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100.Compensation for Damages (Law), Epinephrine (Drug), Suits and Litigation (Civil), Pfizer Inc, Viatris, EpiPen, Mylan, Medical DevicesRead More

Leave a Reply

Your email address will not be published.